正文
Accelerating discovery of liver disease mechanisms
For Filippo Menolascina, Co-Scientist helped turn biomedical literature overload into high-quality hypotheses for metabolic liver disease. The system highlighted promising disease mechanisms and drug combinations, and helped explain why an existing drug benefits only some patients – an idea later supported by Menolascina’s lab tests.
“Co‑Scientist feels like a jetpack for scientists, powering up our ability to identify promising mechanisms. I think we’re on the brink of a scientific revolution that will significantly shorten the iteration cycles needed to achieve breakthroughs.”
Filippo Menolascina, Professor of Engineering Biology, University of Edinburgh